17 results on '"Deva, Djeven P."'
Search Results
2. Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry.
- Author
-
Hagemeyer, Daniel, Merdad, Anas, Sierra, Laura Villegas, Ruberti, Andrea, Kargoli, Faraj, Bouchat, Marine, Boiago, Mauro, Moschovitis, Aris, Deva, Djeven P., Stolz, Lukas, Ong, Geraldine, Peterson, Mark D., Piazza, Nicolo, Taramasso, Maurizio, Dumonteil, Nicolas, Modine, Thomas, Latib, Azeem, Praz, Fabien, Hausleiter, Jörg, and Fam, Neil P.
- Abstract
Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR. The purpose of this multicenter, observational study was to determine the clinical characteristics and short-term outcomes of patients with TR screened for TTVR. Patients underwent TTVR screening at 7 centers on a compassionate-use basis. The primary endpoints were NYHA functional class and TR grade at 30-day follow-up. Secondary endpoints included all-cause mortality, heart failure hospitalization, technical success, and reasons for TTVR screening failure. A total of 149 patients (median age 79 years [Q1-Q3: 72-84 years], 54% women) underwent TTVR screening. The TTVR screening failure rate was 74%, mainly related to large tricuspid annular diameter. Patients undergoing TTVR (n = 38) had significant functional improvements (NYHA functional class I or II from 21% to 68%; P < 0.001), with TR ≤1+ in 97% at 30-day follow-up (P < 0.001 from baseline). Technical success was achieved in 91%, with no intraprocedural mortality or conversion to surgery. At 30-day follow-up, mortality was 8%, heart failure hospitalization 5%, major bleeding 18%, and reintervention 9%. Patients who failed screening for TTVR and subsequently underwent "bailout" transcatheter edge-to-edge repair (n = 26) had favorable outcomes (NYHA functional class I or II from 27% to 58%; P < 0.001), with TR ≤1+ in 43% at 30-day follow-up (P < 0.001 from baseline). This first real-world report of TTVR screening demonstrated a high screening failure rate, mainly related to large tricuspid annular diameter. Patients undergoing TTVR had superior TR reduction and symptom alleviation compared with bailout tricuspid transcatheter edge-to-edge repair, at the cost of greater procedural complications. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy
- Author
-
Ong, Geraldine, Brezden-Masley, Christine, Dhir, Vinita, Deva, Djeven P., Chan, Kelvin K.W., Chow, Chi-Ming, Thavendiranathan, Dinesh, Haq, Rashida, Barfett, Joseph J., Petrella, Teresa M., Connelly, Kim A., and Yan, Andrew T.
- Published
- 2018
- Full Text
- View/download PDF
4. Impact of Empagliflozin on Left Ventricular Strain: Insights From the EMPA-HEART CardioLink-6 Randomized Clinical Trial.
- Author
-
Moses, Samson, Verma, Subodh, Mazer, C. David, Teoh, Hwee, Quan, Adrian, Jimenez-Juan, Laura, Deva, Djeven P., Yan, Andrew T., and Connelly, Kim A.
- Published
- 2022
- Full Text
- View/download PDF
5. Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators.
- Author
-
Tan, Nigel S., Deva, Djeven P., Connelly, Kim A., Angaran, Paul, Mangat, Iqwal, Jimenez-Juan, Laura, Ng, Ming-Yen, Ahmad, Kamran, Kotha, Vamshi K., Lima, Joao A. C., Crean, Andrew M., Dorian, Paul, and Yan, Andrew T.
- Subjects
STATISTICS ,CONFIDENCE intervals ,PREDICTIVE tests ,CARDIOMYOPATHIES ,LEFT ventricular dysfunction ,MULTIVARIATE analysis ,MAGNETIC resonance imaging ,IMPLANTABLE cardioverter-defibrillators ,TERTIARY care ,REGRESSION analysis ,CARDIAC arrest ,BLIND experiment ,DESCRIPTIVE statistics ,PROPORTIONAL hazards models - Abstract
Background: Cardiovascular magnetic resonance (CMR) is increasingly used in the evaluation of patients who are potential candidates for implantable cardioverter-defibrillator (ICD) therapy to assess left ventricular (LV) ejection fraction (LVEF), myocardial fibrosis, and etiology of cardiomyopathy. It is unclear whether CMR-derived strain measurements are predictive of appropriate shocks and death among patients who receive an ICD. We evaluated the prognostic value of LV strain parameters on feature-tracking (FT) CMR in patients who underwent subsequent ICD implant for primary or secondary prevention of sudden cardiac death. Methods: Consecutive patients from 2 Canadian tertiary care hospitals who underwent ICD implant and had a pre-implant CMR scan were included. Using FT-CMR, a single, blinded, reader measured LV global longitudinal (GLS), circumferential (GCS), and radial (GRS) strain. Cox proportional hazards regression was performed to assess the associations between strain measurements and the primary composite endpoint of all-cause death or appropriate ICD shock that was independently ascertained. Results: Of 364 patients (mean 61 years, mean LVEF 32%), 64(17.6%) died and 118(32.4%) reached the primary endpoint over a median follow-up of 62 months. Univariate analyses showed significant associations between GLS, GCS, and GRS and appropriate ICD shocks or death (all p < 0.01). In multivariable Cox models incorporating LVEF, GLS remained an independent predictor of both the primary endpoint (HR 1.05 per 1% higher GLS, 95% CI 1.01–1.09, p = 0.010) and death alone (HR 1.06 per 1% higher GLS, 95% CI 1.02–1.11, p = 0.003). There was no significant interaction between GLS and indication for ICD implant, presence of ischemic heart disease or late gadolinium enhancement (all p > 0.30). Conclusions: GLS by FT-CMR is an independent predictor of appropriate shocks or mortality in ICD patients, beyond conventional prognosticators including LVEF. Further study is needed to elucidate the role of LV strain analysis to refine risk stratification in routine assessment of ICD treatment benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator.
- Author
-
Urzua Fresno, Camila M., Folador, Luciano, Shalmon, Tamar, Hamad, Faisal Mhd. Dib, Singh, Sheldon M., Karur, Gauri R., Tan, Nigel S., Mangat, Iqwal, Kirpalani, Anish, Chacko, Binita Riya, Jimenez-Juan, Laura, Yan, Andrew T., and Deva, Djeven P.
- Subjects
MORTALITY risk factors ,LEFT heart ventricle ,VENTRICULAR ejection fraction ,SCIENTIFIC observation ,CONFIDENCE intervals ,CARDIOMYOPATHIES ,MULTIVARIATE analysis ,MAGNETIC resonance imaging ,IMPLANTABLE cardioverter-defibrillators ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,CARDIOVASCULAR disease diagnosis ,LONGITUDINAL method ,PROPORTIONAL hazards models - Abstract
Background: Current indications for implantable cardioverter defibrillator (ICD) implantation for sudden cardiac death prevention rely primarily on left ventricular (LV) ejection fraction (LVEF). Currently, two different contouring methods by cardiovascular magnetic resonance (CMR) are used for LVEF calculation. We evaluated the comparative prognostic value of these two methods in the ICD population, and if measures of LV geometry added predictive value. Methods: In this retrospective, 2-center observational cohort study, patients underwent CMR prior to ICD implantation for primary or secondary prevention from January 2005 to December 2018. Two readers, blinded to all clinical and outcome data assessed CMR studies by: (a) including the LV trabeculae and papillary muscles (TPM) (trabeculated endocardial contours), and (b) excluding LV TPM (rounded endocardial contours) from the total LV mass for calculation of LVEF, LV volumes and mass. LV sphericity and sphere-volume indices were also calculated. The primary outcome was a composite of appropriate ICD shocks or death. Results: Of the 372 consecutive eligible patients, 129 patients (34.7%) had appropriate ICD shock, and 65 (17.5%) died over a median duration follow-up of 61 months (IQR 38–103). LVEF was higher when including TPM versus excluding TPM (36% vs. 31%, p < 0.001). The rate of appropriate ICD shock or all-cause death was higher among patients with lower LVEF both including and excluding TPM (p for trend = 0.019 and 0.004, respectively). In multivariable models adjusting for age, primary prevention, ischemic heart disease and late gadolinium enhancement, both LVEF (HR per 10% including TPM 0.814 [95%CI 0.688–0.962] p = 0.016, vs. HR per 10% excluding TPM 0.780 [95%CI 0.639–0.951] p = 0.014) and LV mass index (HR per 10 g/m
2 including TPM 1.099 [95%CI 1.027–1.175] p = 0.006; HR per 10 g/m2 excluding TPM 1.126 [95%CI 1.032–1.228] p = 0.008) had independent prognostic value. Higher LV end-systolic volumes and LV sphericity were significantly associated with increased mortality but showed no added prognostic value. Conclusion: Both CMR post-processing methods showed similar prognostic value and can be used for LVEF assessment. LVEF and indexed LV mass are independent predictors for appropriate ICD shocks and all-cause mortality in the ICD population. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
7. Cost benefit analysis of portable chest radiography through glass: Initial experience at a tertiary care centre during COVID-19 pandemic.
- Author
-
Liu, Tian Yang, Rai, Archana, Ditkofsky, Noah, Deva, Djeven P., Dowdell, Timothy R., Ackery, Alun Duncan, and Mathur, Shobhit
- Subjects
CHEST X rays ,TERTIARY care ,OCCUPATIONAL exposure ,MEDICAL equipment safety measures ,COST effectiveness ,PERSONAL protective equipment ,COVID-19 pandemic ,MEDICAL equipment - Abstract
Copyright of Journal of Medical Imaging & Radiation Sciences is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
8. Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System: A Multicenter, Observational, First-in-Human Experience.
- Author
-
Fam, Neil P., von Bardeleben, Ralph Stephan, Hensey, Mark, Kodali, Susheel K., Smith, Robert L., Hausleiter, Jörg, Ong, Geraldine, Boone, Robert, Ruf, Tobias, George, Isaac, Szerlip, Molly, Näbauer, Michael, Ali, Faeez M., Moss, Robert, Bapat, Vinayak, Schnitzler, Katharina, Kreidel, Felix, Ye, Jian, Deva, Djeven P., and Mack, Michael J.
- Abstract
The purpose of this observational first-in-human experience was to investigate the feasibility and safety of the EVOQUE tricuspid valve replacement system and its impact on short-term clinical outcomes. Transcatheter tricuspid intervention is a promising option for selected patients with severe tricuspid regurgitation (TR). Although transcatheter leaflet repair is an option for some, transcatheter tricuspid valve replacement (TTVR) may be applicable to a broader population. Twenty-five patients with severe TR underwent EVOQUE TTVR in a compassionate-use experience. The primary outcome was technical success, with NYHA (NYHA) functional class, TR grade, and major adverse cardiac and cerebrovascular events assessed at 30-day follow-up. All patients (mean age 76 ± 3 years, 88% women) were at high surgical risk (mean Society of Thoracic Surgeons risk score 9.1 ± 2.3%), with 96% in NYHA functional class III or IV. TR etiology was predominantly functional, with mean tricuspid annular diameter of 44.8 ± 7.8 mm and mean tricuspid annular plane systolic excursion of 16 ± 2 mm. Technical success was 92%, with no intraprocedural mortality or conversion to surgery. At 30-day follow-up, mortality was 0%, 76% of patients were in NYHA functional class I or II, and TR grade was ≤2+ in 96%. Major bleeding occurred in 3 patients (12%), 2 patients (8%) required pacemaker implantation, and 1 patient (4%) required dialysis. This first-in-human experience evaluating EVOQUE TTVR demonstrated high technical success, acceptable safety, and significant clinical improvement. Larger prospective studies are needed to confirm durability and safety and the impact on long-term clinical outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Cardiac MRI and radionuclide ventriculography for measurement of left ventricular ejection fraction in ICD candidates.
- Author
-
Kotha, Vamshi K., Deva, Djeven P., Connelly, Kim A., Freeman, Michael R., Yan, Raymond T., Mangat, Iqwal, Kirpalani, Anish, Barfett, Joseph J., Sloninko, Joanna, Lin, Hui Ming, Graham, John J., Crean, Andrew M., Jimenez-Juan, Laura, Dorian, Paul, and Yan, Andrew T.
- Subjects
- *
VENTRICULAR ejection fraction , *CARDIAC magnetic resonance imaging , *IMPLANTABLE cardioverter-defibrillators , *CARDIAC radionuclide imaging , *BLAND-Altman plot - Abstract
Objective Current guidelines provide left ventricular ejection fraction (LVEF) criterion for use of implantable cardioverter defibrillators (ICD) but do not specify which modality to use for measurement. We compared LVEF measurements by radionuclide ventriculography (RNV) vs cardiac MRI (CMR) in ICD candidates to assess impact on clinical decision making. Methods This single-centre study included 124 consecutive patients referred for assessment of ICD implantation who underwent RNV and CMR within 30 days for LVEF measurement. RNV and CMR were interpreted independently by experienced readers. Results Among 124 patients (age 64 ± 11 years, 77% male), median interval between CMR and RNV was 1 day; mean LVEF was 32 ± 12% by CMR and 33 ± 11% by RNV ( p = 0.60). LVEF by CMR and RNV showed good correlation, but Bland-Altman analysis showed relatively wide limits of agreement (−12.1 to 11.4). CMR LVEF reclassified 26 (21%) patients compared to RNV LVEF (kappa = 0.58). LVEF by both modalities showed good interobserver reproducibility (ICC 0.96 and 0.94, respectively) (limits of agreement −7.27 to 5.75 and −8.63 to 6.34, respectively). Conclusion Although LVEF measurements by CMR and RNV show moderate agreement, there is frequent reclassification of patients for ICD placement based on LVEF between these modalities. Future studies should determine if a particular imaging modality for LVEF measurement may enhance ICD decision making and treatment benefit. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Prognostic value of visually detected coronary artery calcification on unenhanced non-gated thoracic computed tomography for prediction of non-fatal myocardial infarction and all-cause mortality.
- Author
-
Shao, Lisa, Yan, Andrew T., Lebovic, Gerald, Wong, Harvey H., Kirpalani, Anish, and Deva, Djeven P.
- Abstract
Purpose To determine the prognostic value of visually detected coronary artery calcification (CAC) on unenhanced non-gated thoracic computed tomography (CT) for non-fatal myocardial infarction (MI) and all-cause mortality. Methods This retrospective single-centre cohort study comprised of 410 consecutive patients aged 40–80 years without any known cardiovascular disease at baseline. CT images without electrocardiogram-gating were acquired for a variety of respiratory medicine indications. CAC was examined by a single reader blinded to clinical data and outcome, using 1) the Agatston coronary calcium score (CCS), 2) visual CAC and 3) number of visually calcified coronary arteries. Results Visible CAC was identified in 201 (49.0%) of the 410 patients (60.5 ± 10.0 years old, 42.4% males). After a median follow up of 7.0 years, 39 patients (9.5%) experienced an event (death or non-fatal MI). After adjustment for cardiovascular risk factors, those with 1) higher CCS, 2) presence of visual CAC or 3) greater number of calcified coronary arteries by visual assessment, had an increased risk of adverse outcome (all p-value <0.05). There was no significant difference in c-statistics of the three methods of assessment (0.81, 0.80, 0.81 respectively), indicating that simple visual assessment of CAC may have a prognostic value similar to CCS. Conclusion Among patients with no known cardiovascular disease who underwent unenhanced non-gated CT for a pulmonary-related indication, visually detected CAC was a strong independent predictor of non-fatal MI and all-cause mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study.
- Author
-
Barthur, Ashita, Brezden-Masley, Christine, Connelly, Kim A., Dhir, Vinita, Chan, Kelvin K. W., Haq, Rashida, Kirpalani, Anish, Barfett, Joseph J., Jimenez-Juan, Laura, Karur, Gauri R., Deva, Djeven P., and Yan, Andrew T.
- Subjects
BREAST tumor diagnosis ,RIGHT heart ventricle ,BREAST tumors ,CARDIOTOXICITY ,CONFIDENCE intervals ,STATISTICAL correlation ,LEFT heart ventricle ,HEART physiology ,LONGITUDINAL method ,MAGNETIC resonance imaging ,SCIENTIFIC observation ,ONCOGENES ,REGRESSION analysis ,TRASTUZUMAB ,STROKE volume (Cardiac output) ,VENTRICULAR ejection fraction ,WOUNDS & injuries ,THERAPEUTICS - Abstract
Background: There are limited data on the effects of trastuzumab on the right ventricle (RV). Therefore, we sought to evaluate the temporal changes in right ventricular (RV) structure and function as measured by cardiovascular magnetic resonance (CMR), and their relationship with left ventricular (LV) structure and function in breast cancer patients treated with trastuzumab. Methods: Prospective, longitudinal, observational study involving 41 women with HER2+ breast cancer who underwent serial CMR at baseline, 6, 12, and 18 months after initiation of trastuzumab. A single blinded observer measured RV parameters on de-identified CMRs in a random order. Linear mixed models were used to investigate temporal changes in RV parameters. Results: Of the 41 women (age 52 ± 11 years), only one patient experienced trastuzumab-induced cardiotoxicity. Compared to baseline, there were small but significant increases in the RV end-diastolic volume at 6 months (p = 0.002) and RV end-systolic volume at 6 and 12 months (p < 0.001 for both), but not at 18 months (p = 0.82 and 0.13 respectively). RV ejection fraction (RVEF), when compared to baseline (58.3%, 95% CI 57.1-59.5%), showed corresponding decreases at 6 months (53.9%, 95% CI 52.5-55.4%, p < 0.001) and 12 months (55%, 95% CI 53.8-56.2%, p < 0.001) that recovered at 18 months (56.6%, 95% CI 55.1-58.0%, p = 0.08). Although the temporal pattern of changes in LVEF and RVEF were similar, there was no significant correlation between RVEF and LVEF at baseline (r = 0.29, p = 0.07) or between their changes at 6 months (r = 0.24, p = 0.17). Conclusion: In patients receiving trastuzumab without overt cardiotoxicity, there is a subtle but significant deleterious effect on RV structure and function that recover at 18 months, which can be detected by CMR. Furthermore, monitoring of LVEF alone may not be sufficient in detecting early RV injury. These novel findings provide further support for CMR in monitoring early cardiotoxicity. Trial registration: ClinicalTrials.gov Identifier: NCT01022086. Date of registration: November 27, 2009. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Tracking and Resolving CT Dose Metric Outliers Using Root-Cause Analysis.
- Author
-
Chen, Yingming Amy, MacGregor, Kate, Li, Iris, Concepcion, Lianne, Deva, Djeven Parameshvara, Dowdell, Timothy, and Gray, Bruce Garstang
- Abstract
Purpose: The aim of this study was to examine the frequency and type of outlier dose metrics for three common CT examination types on the basis of a root-cause analysis (RCA) approach.Methods: Institutional review board approval was obtained for this retrospective observational study. The requirement to obtain informed consent was waived. Between January 2010 and December 2013, radiation dose metric data from 34,615 CT examinations, including 26,878 routine noncontrast CT head, 2,992 CT pulmonary angiographic (CTPA), and 4,745 renal colic examinations, were extracted from a radiation dose index monitoring database and manually cleaned. Dose outliers were identified on the basis of the statistical distribution of volumetric CT dose index and dose-length product for each examination type; values higher than the 99th percentile and less than the 1st percentile were flagged for RCA.Results: There were 397 noncontrast CT head, 52 CTPA, and 80 renal colic outliers. Root causes for high-outlier examinations included repeat examinations due to patient motion (n = 122 [31%]), modified protocols mislabeled as "routine" (n = 69 [18%]), higher dose examinations for patients with large body habitus (n = 27 [7%]), repeat examinations due to technical artifacts (n = 20 [5%]), and repeat examinations due to suboptimal contrast timing (CTPA examinations) (n = 18 [5%]). Root causes for low-outlier examinations included low-dose protocols (n = 112 [29%]) and aborted examinations (n = 8 [2%]). On the basis of examination frequency over a 3-month period, the 90th and 10th percentile values were set in the radiation dose index monitoring database as thresholds for sending notifications to staff members responsible for outlier investigations.Conclusions: Systematic RCA of dose outliers identifies sources of variation and dose excess and pinpoints specific protocol and technical shortcomings for corrective action. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
13. Relationship between different blood pressure measurements and left ventricular mass by cardiac magnetic resonance imaging in end–stage renal disease.
- Author
-
Merchant, Asad, Wald, Ron, Goldstein, Marc B., Yuen, Darren, Kirpalani, Anish, Dacouris, Niki, Ray, Joel G., Kiaii, Mercedeh, Leipsic, Jonathan, Kotha, Vamshi, Deva, Djeven, and Yan, Andrew T.
- Abstract
Hypertension is prevalent in patients with end–stage renal disease and is strongly associated with left ventricular hypertrophy (LVH), an independent predictor of cardiovascular mortality. Blood pressure (BP) monitoring in hemodialysis patients may be unreliable because of its lability and variability. We compared different methods of BP measurement and their relationship with LVH on cardiac magnetic resonance imaging. Sixty patients undergoing chronic hemodialysis at a single dialysis center had BP recorded at each dialysis session over 12 weeks: pre–dialysis, initial dialysis, nadir during dialysis, and post–dialysis. Forty–five of these patients also underwent 44–hour inter–dialytic ambulatory BP monitoring. Left ventricular mass index (LVMI) was measured using cardiac magnetic resonance imaging and the presence of LVH was ascertained. Receiver operator characteristic curves were generated for each BP measurement for predicting LVH. The mean LVMI was 68 g/m 2 (SD = 15 g/m 2 ); 13/60 patients (22%) had LVH. Mean arterial pressure measured shortly after initiation of dialysis session was most strongly correlated with LVMI (Pearson correlation coefficient r = 0.59, P < .0001). LVH was best predicted by post–dialysis systolic BP (area under the curve, 0.83; 95% confidence interval, 0.72–0.94) and initial dialysis systolic BP (area under the curve, 0.81; 95% confidence interval, 0.70–0.92). Forty–four–hour ambulatory BP and BP variability did not significantly predict LVH. Initial dialysis mean arterial pressure and systolic BP and post–dialysis systolic BP are the strongest predictors of LVH, and may represent the potentially best treatment targets in hemodialysis patients to prevent end–organ damage. Further studies are needed to confirm whether treatment targeting these BP measurements can optimize cardiovascular outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Transfemoral Transcatheter Tricuspid Valve Replacement.
- Author
-
Fam, Neil P., Ong, Geraldine, Deva, Djeven P., and Peterson, Mark D.
- Published
- 2020
- Full Text
- View/download PDF
15. Left Main Coronary Artery Compression Long Term After Repair of Conotruncal Lesions: The Bow String Conduit.
- Author
-
Jacques, Frederic, Kotani, Yasuhiro, Deva, Djeven P., Moller, Thomas, Oechslin, Erwin, Horlick, Eric, Osten, Mark, Crean, Andrew, Benson, Lee N., Wintersperger, Bernd J., and Caldarone, Christopher A.
- Subjects
CORONARY disease ,CORONARY artery surgery ,CARDIAC surgery ,HEART blood-vessels ,VASCULAR diseases ,CARDIOVASCULAR surgery - Abstract
We report 4 cases of left main coronary artery (LMCA) compression after remote repair of conotruncal lesions and their successful surgical management. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
16. Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation.
- Author
-
Gong, Inna Y., Al-Amro, Bandar, Prasad, G. V. Ramesh, Connelly, Philip W., Wald, Rachel M., Wald, Ron, Deva, Djeven P., Leong-Poi, Howard, Nash, Michelle M., Yuan, Weiqiu, Gunaratnam, Lakshman, Kim, S. Joseph, Lok, Charmaine E., Connelly, Kim A., and Yan, Andrew T.
- Subjects
CHRONIC kidney failure ,CARDIOVASCULAR disease diagnosis ,LEFT heart ventricle ,HEART physiology ,HEMODIALYSIS ,KIDNEY transplantation ,LONGITUDINAL method ,MAGNETIC resonance imaging ,MEDICAL cooperation ,POSTOPERATIVE period ,RESEARCH ,STATISTICS ,DATA analysis ,STROKE volume (Cardiac output) ,SURGERY - Abstract
Background: Cardiovascular disease is a significant cause of morbidity and mortality in patients with end-stage renal disease (ESRD) and kidney transplant (KT) patients. Compared with left ventricular (LV) ejection fraction (LVEF), LV strain has emerged as an important marker of LV function as it is less load dependent. We sought to evaluate changes in LV strain using cardiovascular magnetic resonance imaging (CMR) in ESRD patients who received KT, to determine whether KT may improve LV function. Methods: We conducted a prospective multi-centre longitudinal study of 79 ESRD patients (40 on dialysis, 39 underwent KT). CMR was performed at baseline and at 12 months after KT. Results: Among 79 participants (mean age 55 years; 30% women), KT patients had significant improvement in global circumferential strain (GCS) (p = 0.007) and global radial strain (GRS) (p = 0.003), but a decline in global longitudinal strain (GLS) over 12 months (p = 0.026), while no significant change in any LV strain was observed in the ongoing dialysis group. For KT patients, the improvement in LV strain paralleled improvement in LVEF (57.4 ± 6.4% at baseline, 60.6% ± 6.9% at 12 months; p = 0.001). For entire cohort, over 12 months, change in LVEF was significantly correlated with change in GCS (Spearman's r = − 0.42, p < 0.001), GRS (Spearman's r = 0.64, p < 0.001), and GLS (Spearman's r = − 0.34, p = 0.002). Improvements in GCS and GRS over 12 months were significantly correlated with reductions in LV end-diastolic volume index and LV end-systolic volume index (all p < 0.05), but not with change in blood pressure (all p > 0.10). Conclusions: Compared with continuation of dialysis, KT was associated with significant improvements in LV strain metrics of GCS and GRS after 12 months, which did not correlate with blood pressure change. This supports the notion that KT has favorable effects on LV function beyond volume and blood pessure control. Larger studies with longer follow-up are needed to confirm these findings. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
17. Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy.
- Author
-
Deva, Djeven P., Williams, Lynne K., Care, Melanie, Siminovitch, Katherine A., Moshonov, Hadas, Wintersperger, Bernd J., Rakowski, Harry, and Crean, Andrew M.
- Subjects
CARDIAC hypertrophy ,BIOMARKERS ,CONFERENCES & conventions ,HEART septum ,MAGNETIC resonance imaging ,GENETIC mutation ,GENETIC testing ,DIAGNOSIS - Abstract
An abstract of the article "Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy," by Djeven P. Deva and colleagues is presented.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.